Back
Armen A. Vidian
Armen has nearly 30 years of experience as an engineer, entrepreneur, and investor in technology and healthcare. Armen started his career creating first-in-class products in medical technology. He then co-founded BlueTalon [acquired by MSFT], which initially focused on the interface between data federation and clinical trials. His experience in healthcare and technology has focused his interests on the application of generative AI, robotics, AR/VR, and brain-computer interfaces in healthcare and the life sciences.
After BlueTalon, Armen was an early Partner at DCVC, the first venture capital firm with an AI-centric thesis. At DCVC, he played a leadership role in the investment of the first companies applying AI to healthcare and the life sciences. Some of Armen’s board responsibilities included: Board Chairman at Caption Health [acquired by GE HealthCare]; and Board Director at Proprio. In addition to these responsibilities, Armen led or co-led investment in AbCellera [NASD: ABCL], Recursion [NASD: RXRX], and Healthmode [NASD:MNMD].
Armen holds an S.B. in Mechanical Engineering from the Massachusetts Institute of Technology (MIT) and an M.S. in Management Science and Engineering from Stanford University. His history with data and healthcare goes back to college, during which he co-authored a paper on the use of autoregressive moving average analysis (ARMA) to characterize baroreflex gain in a 1996 issue of the American Journal of Physiology: Heart and Circulation. Originally from Racine, Wisconsin, Armen’s perspective as a venture capitalist is influenced as a first generation college graduate.
